Advertisement
APVO vs OTLK
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APVO is a Hold and OTLK is a Hold.
Momentum Indicator for APVO turns negative, indicating new downward trend
APVO saw its Momentum Indicator move below the 0 level on October 01, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 99 similar instances where the indicator turned negative. In 97 of the 99 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where APVO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for APVO entered a downward trend on September 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where APVO's RSI Indicator exited the oversold zone, 38 of 47 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for APVO just turned positive on September 14, 2026. Looking at past instances where APVO's MACD turned positive, the stock continued to rise in 33 of 43 cases over the following month. The odds of a continued upward trend are 77%.
Following a +4.37% 3-day Advance, the price is estimated to grow further. Considering data from situations where APVO advanced for three days, in 145 of 189 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 9 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.572) is normal, around the industry mean (26.782). P/E Ratio (0.004) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (437.542).
The Tickeron Seasonality Score of 14 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. APVO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. APVO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
Momentum Indicator for OTLK turns negative, indicating new downward trend
OTLK saw its Momentum Indicator move below the 0 level on September 24, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 93 similar instances where the indicator turned negative. In 82 of the 93 cases, the stock moved further down in the following days. The odds of a decline are at 88%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for OTLK turned negative on October 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 35 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 81%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OTLK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where OTLK's RSI Indicator exited the oversold zone, 25 of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +3.56% 3-day Advance, the price is estimated to grow further. Considering data from situations where OTLK advanced for three days, in 195 of 239 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
OTLK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 122 of 153 cases where OTLK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 80%.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 10 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating steady price growth. OTLK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 77 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (39.216) is normal, around the industry mean (26.782). P/E Ratio (0.594) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (128.205) is also within normal values, averaging (437.542).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OTLK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
APVO | OTLK | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 95 | 3 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 9 Undervalued | 77 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 91 | 65 | |
P/E GROWTH RATING 1..100 | 100 | 14 | |
SEASONALITY SCORE 1..100 | 14 | 10 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
APVO's Valuation (9) in the Biotechnology industry is significantly better than the same rating for OTLK (77). This means that APVO’s stock grew significantly faster than OTLK’s over the last 12 months.
APVO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as OTLK (100). This means that APVO’s stock grew similarly to OTLK’s over the last 12 months.
APVO's SMR Rating (100) in the Biotechnology industry is in the same range as OTLK (100). This means that APVO’s stock grew similarly to OTLK’s over the last 12 months.
OTLK's Price Growth Rating (65) in the Biotechnology industry is in the same range as APVO (91). This means that OTLK’s stock grew similarly to APVO’s over the last 12 months.
OTLK's P/E Growth Rating (14) in the Biotechnology industry is significantly better than the same rating for APVO (100). This means that OTLK’s stock grew significantly faster than APVO’s over the last 12 months.
| APVO | OTLK | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 81% | 1 day ago 89% |
| Stochastic ODDS (%) | 1 day ago 89% | 1 day ago 89% |
| Momentum ODDS (%) | 1 day ago 90% | 1 day ago 88% |
| MACD ODDS (%) | 3 days ago 77% | 1 day ago 81% |
| TrendWeek ODDS (%) | 1 day ago 90% | 1 day ago 85% |
| TrendMonth ODDS (%) | 1 day ago 90% | 1 day ago 84% |
| Advances ODDS (%) | 19 days ago 77% | 12 days ago 82% |
| Declines ODDS (%) | 8 days ago 90% | 3 days ago 84% |
| BollingerBands ODDS (%) | N/A | 1 day ago 90% |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 80% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
APVO’s FA Score shows that 1 FA rating(s) are green while OTLK’s FA Score has 1 green FA rating(s).
- APVO’s FA Score: 1 green, 4 red.
- OTLK’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
APVO’s TA Score shows that 4 TA indicator(s) are bullish while OTLK’s TA Score has 5 bullish TA indicator(s).
- APVO’s TA Score: 4 bullish, 3 bearish.
- OTLK’s TA Score: 5 bullish, 3 bearish.
Price Growth
APVO (@Biotechnology) experienced а -5.56% price change this week, while OTLK (@Biotechnology) price change was -11.35% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -7.32%. For the same industry, the average monthly price growth was -15.10%, and the average quarterly price growth was -18.48%.
Reported Earning Dates
APVO is expected to report earnings on Nov 05, 2026.
Industries' Descriptions
@Biotechnology (-7.32% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
APVO and
Correlation & Price change
A.I.dvisor indicates that over the last year, APVO has been closely correlated with GNPX. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if APVO jumps, then GNPX could also see price increases.
| Ticker / NAME | Correlation To APVO | 1D Price Change % | ||
|---|---|---|---|---|
| APVO | 100% | -1.73% | ||
| GNPX - APVO | 92% Closely correlated | -1.72% | ||
| ICU - APVO | 92% Closely correlated | +1.66% | ||
| MLEC - APVO | 78% Closely correlated | N/A | ||
| LNAI - APVO | 60% Loosely correlated | -7.48% | ||
| NCEL - APVO | 50% Loosely correlated | +7.28% | ||
More | ||||
OTLK and
Correlation & Price change
A.I.dvisor indicates that over the last year, OTLK has been loosely correlated with APVO. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if OTLK jumps, then APVO could also see price increases.
| Ticker / NAME | Correlation To OTLK | 1D Price Change % | ||
|---|---|---|---|---|
| OTLK | 100% | +6.34% | ||
| APVO - OTLK | 45% Loosely correlated | -1.73% | ||
| ICU - OTLK | 36% Loosely correlated | +1.66% | ||
| GNPX - OTLK | 34% Loosely correlated | -1.72% | ||
| CYTK - OTLK | 33% Loosely correlated | +0.77% | ||
| PDSB - OTLK | 33% Loosely correlated | -7.80% | ||
More | ||||